(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
SIB-1508Y Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid Compound (Entity type)	0.3038863241672516
R-59022 Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid Compound (Entity type)	0.3716908097267151
Phenolphthalein Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid Compound (Entity type)	0.4574616551399231
Iopamidol Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid Compound (Entity type)	0.3030657470226288
(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	CA12 Gene (Entity type)	0.010059081
(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	SLC1A3 Gene (Entity type)	0.011841635
(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	MSLN Gene (Entity type)	-0.009945644
Iobenguane Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid Compound (Entity type)	0.3199676275253296
(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	TUBB2A Gene (Entity type)	0.011519903
(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	ALOX5AP Gene (Entity type)	0.011515293

SIB-1508Y
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid
Compound (Entity type)
0.3038863241672516

R-59022
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid
Compound (Entity type)
0.3716908097267151

Phenolphthalein
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid
Compound (Entity type)
0.4574616551399231

Iopamidol
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid
Compound (Entity type)
0.3030657470226288

(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
CA12
Gene (Entity type)
0.010059081

(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
SLC1A3
Gene (Entity type)
0.011841635

(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
MSLN
Gene (Entity type)
-0.009945644

Iobenguane
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid
Compound (Entity type)
0.3199676275253296

(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
TUBB2A
Gene (Entity type)
0.011519903

(6S,9S,12S,13S,17S,20R,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
ALOX5AP
Gene (Entity type)
0.011515293

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.